ITMN 10.73 0.54 / InterMune, Inc. FDA | Benzinga

Monday, May 21, 2012

Intermune Will Divest Rights to Vidara for $55M in Cash, Plus 2 Year Royalty Stream (ITMN, News, Asset Sales, FDA / Mon, 04:52pm)

Thursday, April 05, 2012

France's Transparency Commission (CT) Issues Favorable Opinion for Reimbursement of Esbriet; Intermune Expresses Confidence In Ascend Phase 3 Study Outcome; Updates Timeline (ITMN, News, Contracts, FDA / Thu, 01:31pm)

Thursday, March 15, 2012

Intermune Up 17% After German Agency Says Esbriet Offers Benefit (ITMN, News, FDA, Intraday Update, Movers / Thu, 09:58am)
Esbriet (pirfenidone) Benefit Granted by German Federal Joint Committee (ITMN, News, FDA, Global / Thu, 08:14am)

Monday, January 09, 2012

Just What The Doctor Ordered: 4 ETFs For Biotech M&A (ACHN, AFFX, ALXN, AMGN, BBH, BIIB, BMRN, BMY, CELG, DNDN, FBT, GILD, IDIX, INHX, ITMN, Long Ideas, News, PSCH, REGN, Sector ETFs, XBI, Short Ideas, Specialty ETFs, New ETFs, Rumors, Small Cap Analysis, Technicals, FDA, M&A, Events, Intraday Update, After-Hours Center, Markets, Movers, Trading Ideas, ETFs / Mon, 04:49pm)

Thursday, January 05, 2012

InterMune Reports Preliminary Fourth Quarter 2011 Esbriet Revenue and Other Recent Business Highlights (Earnings, IPF, ITMN, News, NPP, FDA / Thu, 08:03am)

Friday, December 16, 2011

IQWIG Publishes Early Benefit Assessment for Pirfenidone (ITMN, News, FDA / Fri, 07:55am)

Thursday, December 15, 2011

UPDATE: German Science Board that Contracts with Government Raises Doubt about Pirfenidone Benefit (ITMN, News, Rumors, FDA, Global, Movers / Thu, 12:21pm)

Monday, September 12, 2011

InterMune Announces Launch of Esbriet in Germany (ITMN, News, FDA / Mon, 07:00am)

Thursday, July 07, 2011

InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF (ITMN, News, FDA / Thu, 07:10pm)

Monday, May 16, 2011

Intermune Announces Presentation Of Positive Pirfenidone Data At The International Conference Of The American Thoracic Society (ITMN, News, FDA / Mon, 07:20am)

Friday, December 17, 2010

InterMune Continues To Skyrocket (ITMN) (CHMP, ITMN, News, FDA, Movers / Fri, 03:57pm)

Monday, August 16, 2010

InterMune, Inc. Sees Positive Chatter this Morning (ITMN, News, Rumors, FDA, Markets / Mon, 09:56am)
Benzinga’s Top Pre-Market NASDAQ Gainers (SYUT, EGL, JAZZ, ITMN) (EGLE, ITMN, JAZZ, Long Ideas, News, SYUT, Upgrades, FDA, Pre-Market Outlook, Intraday Update, Markets, Analyst Ratings, Movers, Trading Ideas / Mon, 08:28am)

Wednesday, May 05, 2010

ITMN Shares Continue Their Free Fall; Pull Down Biotechnology Index (ITMN, News, Short Ideas, FDA, Markets, Movers, Trading Ideas / Wed, 10:42am)
F.D.A. Rejects Lung Fibrosis Drug (ITMN) (ITMN, News, FDA, Intraday Update, Markets, Movers / Wed, 07:23am)

Tuesday, May 04, 2010

Benzinga's After Hours Decliners (MYGN, ITMN, TRLG) (ITMN, MYGN, TRLG, FDA, Intraday Update, After-Hours Center, Movers / Tue, 05:45pm)
InterMune Plummets After Hours (ITMN) (IPF, ITMN, News, Short Ideas, FDA, Intraday Update, After-Hours Center, Movers, Trading Ideas / Tue, 05:37pm)
InterMune Halted Pending News (ITMN, News, Short Ideas, Options, FDA, Movers, Trading Ideas / Tue, 01:57pm)

Wednesday, March 10, 2010

Thomas Weisel Partners More Than Double InterMune (ITMN) Price Target To $55 (Analyst Color, ITMN, News, Price Target, FDA, Markets, Analyst Ratings, Movers / Wed, 09:15am)

Tuesday, March 09, 2010

InterMune (ITMN) Shares Jump 63% After FDA Announcement (ITMN, FDA, Markets, Movers / Tue, 06:56pm)

Monday, March 08, 2010

Wells Fargo Securities Rates InterMune (ITMN) Market Perform (Analyst Color, ITMN, News, FDA, Markets, Analyst Ratings / Mon, 12:37pm)